A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease

Por Tanabe, Akie, Yamamura, Yukio, Kasahara, Jiro, Morigaki, Ryoma, Kaji, Ryuji, Goto, Satoshi
Publicado em 2014

Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease

Por Kadoguchi, Naoto, Okabe, Shinji, Yamamura, Yukio, Shono, Misaki, Fukano, Tatsuya, Tanabe, Akie, Yokoyama, Hironori, Kasahara, Jiro
Publicado em 2014

Quantitative activation-induced manganese-enhanced MRI reveals severity of Parkinson’s disease in mice

Por Kikuta, Satomi, Nakamura, Yukiyo, Yamamura, Yukio, Tamura, Atsushi, Homma, Noriyasu, Yanagawa, Yuchio, Tamura, Hajime, Kasahara, Jiro, Osanai, Makoto
Publicado no Sci Rep (2015)

Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice

Por Yamamura, Yukio, Morigaki, Ryoma, Kasahara, Jiro, Yokoyama, Hironori, Tanabe, Akie, Okita, Shinya, Koizumi, Hidetaka, Nagahiro, Shinji, Kaji, Ryuji, Goto, Satoshi
Publicado em 2013